TELA - TELA Bio, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5180.58M
Enterprise Value 3343.86M
Trailing P/E N/A
Forward P/E 1-6.95
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)13.88
Price/Book (mrq)N/A
Enterprise Value/Revenue 326.43
Enterprise Value/EBITDA 6-18.84

Trading Information

Stock Price History

Beta (5Y Monthly) N/A
52-Week Change 3∞%
S&P500 52-Week Change 321.38%
52 Week High 315.97
52 Week Low 310.78
50-Day Moving Average 314.60
200-Day Moving Average 313.38

Share Statistics

Avg Vol (3 month) 358.4k
Avg Vol (10 day) 324.04k
Shares Outstanding 511.41M
Float 3.09M
% Held by Insiders 14.10%
% Held by Institutions 141.81%
Shares Short (Jan 14, 2020) 496.17k
Short Ratio (Jan 14, 2020) 41.45
Short % of Float (Jan 14, 2020) 42.05%
Short % of Shares Outstanding (Jan 14, 2020) 40.84%
Shares Short (prior month Dec 12, 2019) 449.78k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2018
Most Recent Quarter (mrq)Sep 29, 2019


Profit Margin -178.98%
Operating Margin (ttm)-144.78%

Management Effectiveness

Return on Assets (ttm)N/A
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)13.01M
Revenue Per Share (ttm)43.89
Quarterly Revenue Growth (yoy)79.60%
Gross Profit (ttm)3.73M
EBITDA -18.25M
Net Income Avi to Common (ttm)-32.1M
Diluted EPS (ttm)-108.30
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)10.7M
Total Cash Per Share (mrq)0.94
Total Debt (mrq)30.11M
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)2.79
Book Value Per Share (mrq)-538.04

Cash Flow Statement

Operating Cash Flow (ttm)-24.1M
Levered Free Cash Flow (ttm)N/A